|
2020 Conference Publication Pharmacodynamic evaluation of intermittent versus prolonged infusion dosing regimens of piperacillin/tazobactam in a hollow-fiber infection model against two susceptible Klebsiella pneumoniae clinical isolatesSumi, Chandra Datta, B.Sime, Fekade, Heffernan, Aaron J., Naicker, Saiyuri, Islam, Kamrul, Cottrell, Kyra, Harris, Patrick N.A. and Roberts, Jason A. (2020). Pharmacodynamic evaluation of intermittent versus prolonged infusion dosing regimens of piperacillin/tazobactam in a hollow-fiber infection model against two susceptible Klebsiella pneumoniae clinical isolates. Federation of Infection Societies Conference 2019, Edinburgh, United Kingdom, 11-14 November 2019. London, United Kingdom: The Microbiology Society. doi: 10.1099/acmi.fis2019.po0103 |
|
2020 Journal Article β-Lactam pharmacodynamics in Gram-negative bloodstream infections in the critically illWong, Gloria, Taccone, Fabio, Villois, Paola, Scheetz, Marc H., Rhodes, Nathaniel J., Briscoe, Scott, McWhinney, Brett, Nunez-Nunez, Maria, Ungerer, Jacobus, Lipman, Jeffrey and Roberts, Jason A. (2020). β-Lactam pharmacodynamics in Gram-negative bloodstream infections in the critically ill. Journal of Antimicrobial Chemotherapy, 75 (2), 429-433. doi: 10.1093/jac/dkz437 |
|
2020 Journal Article The challenge of quantifying and managing pharmacokinetic variability of beta-lactams in the critically illCrass, Ryan L., Williams, Paul and Roberts, Jason A. (2020). The challenge of quantifying and managing pharmacokinetic variability of beta-lactams in the critically ill. Anaesthesia Critical Care and Pain Medicine, 39 (1), 27-29. doi: 10.1016/j.accpm.2019.12.008 |
|
2020 Journal Article Oral fosfomycin efficacy with variable urinary exposures following single and multiple doses against Enterobacterales: the importance of heteroresistance on growth outcomeAbbott, Iain J., van Gorp, Elke, Wijma, Rixt A., Meletiadis, Joseph, Roberts, Jason A., Mouton, Johan W. and Peleg, Anton Y. (2020). Oral fosfomycin efficacy with variable urinary exposures following single and multiple doses against Enterobacterales: the importance of heteroresistance on growth outcome. Antimicrobial Agents and Chemotherapy, 64 (3) e01982-19. doi: 10.1128/aac.01982-19 |
|
2020 Journal Article Software for dose adjustment of antimicrobials. Implications for plasma concentrations and pratical limitationsAlves, Geisa Cristina da Silva, Silva, Samuel Dutra da, Chequer, Farah Maria Drumond, Castro, Whocely Victor de, Baldoni, André Oliveira, Farkas, Andras, Daróczi, Gergely, Roberts, Jason Alexander and Sanches, Cristina (2020). Software for dose adjustment of antimicrobials. Implications for plasma concentrations and pratical limitations. Einstein, 18, 1-2. doi: 10.31744/einstein_journal/2020ce5858 |
|
2020 Journal Article The pharmacokinetics of meropenem and piperacillin-tazobactam during sustained low efficiency haemodiafiltration (SLED-HDF)Donnellan, Sine, Wright, Daniel F. B., Roberts, Jason A., Duffull, Stephen B., Schollum, John B. W., Putt, Tracey L., Wallis, Steven C. and Walker, Robert J. (2020). The pharmacokinetics of meropenem and piperacillin-tazobactam during sustained low efficiency haemodiafiltration (SLED-HDF). European Journal of Clinical Pharmacology, 76 (2), 239-247. doi: 10.1007/s00228-019-02792-0 |
|
2020 Conference Publication The burden of venepuncture for kidney transplant patients and interest in possible solutions.Scuderi, C., Parker, S., John, G., McWhinney, B., Ungerer, J., Mallett, A., Roberts, J., Healy, H. and Staatz, C.E. (2020). The burden of venepuncture for kidney transplant patients and interest in possible solutions. . Society of Hospital Pharmacists of Australia, Online, 21-22 November 2020. |
|
2020 Journal Article Linguistic and cultural adaptation to the Portuguese language of antimicrobial dose adjustment softwareSilva, Samuel Dutra da, Alves, Geisa Cristina da Silva, Chequer, Farah Maria Drumond, Farkas, Andras, Daróczi, Gergely, Roberts, Jason A. and Sanches, Cristina (2020). Linguistic and cultural adaptation to the Portuguese language of antimicrobial dose adjustment software. Einstein (São Paulo), 18, 1-8. doi: 10.31744/einstein_journal/2020ao5023 |
|
2020 Journal Article Pharmacokinetic/pharmacodynamic adequacy of polymyxin B against extensively drug-resistant Gram-negative bacteria in critically ill, general ward and cystic fibrosis patient populationsXie, Jiao, Roberts, Jason A., Lipman, Jeffrey, Cai, Yan, Wang, Haitao, Zhao, Nuannuan, Xu, Xiaona, Yang, Shan, Li, Youjia and Zhang, Kanghuai (2020). Pharmacokinetic/pharmacodynamic adequacy of polymyxin B against extensively drug-resistant Gram-negative bacteria in critically ill, general ward and cystic fibrosis patient populations. International Journal of Antimicrobial Agents, 55 (6) 105943, 105943. doi: 10.1016/j.ijantimicag.2020.105943 |
|
2020 Journal Article Meropenem-tobramycin combination regimens combat carbapenem-resistant Pseudomonas aeruginosa in the hollow-fiber infection model simulating augmented renal clearance in critically ill patientsYadav, Rajbharan, Bergen, Phillip J., Rogers, Kate E., Kirkpatrick, Carl M. J., Wallis, Steven C., Huang, Yuling, Bulitta, Jürgen B., Paterson, David L., Lipman, Jeffrey, Nation, Roger L., Roberts, Jason A. and Landersdorfer, Cornelia B. (2020). Meropenem-tobramycin combination regimens combat carbapenem-resistant Pseudomonas aeruginosa in the hollow-fiber infection model simulating augmented renal clearance in critically ill patients. Antimicrobial Agents and Chemotherapy, 64 (1) e01679-19. doi: 10.1128/aac.01679-19 |
|
2020 Journal Article A population pharmacokinetic model-guided evaluation of ceftolozane/tazobactam dosing in critically ill patients undergoing continuous venovenous hemodiafiltrationSime, Fekade B., Lassig-Smith, Melissa, Starr, Therese, Stuart, Janine, Pandey, Saurabh, Parker, Suzanne L., Wallis, Steven C., Lipman, Jeffrey and Roberts, Jason A. (2020). A population pharmacokinetic model-guided evaluation of ceftolozane/tazobactam dosing in critically ill patients undergoing continuous venovenous hemodiafiltration. Antimicrobial Agents and Chemotherapy, 64 (1) e01655. doi: 10.1128/aac.01655-19 |
|
2020 Conference Publication Interest in possible alternative methods to venepuncture-based monitoring in kidney transplant patients.Scuderi, C., Parker, S., John, G., McWhinney, B., Ungerer, J., Mallett, A., Roberts, J., Healy, H. and Staatz, C.E. (2020). Interest in possible alternative methods to venepuncture-based monitoring in kidney transplant patients. . RBWH Symposium, Brisbane, QLD Australia, 7-11 December 2020. |
|
2020 Conference Publication The DECISIVE study: defining beta-lactam concentration in intensive care unit patients – the pharmacokinetics of piperacillin and meropenem in critically ill patients with conserved renal functionAbdul-Aziz, M., Rozali, M., Othman-Jailani, M., Rahman, A. Abd, Sulaiman, H., Atiya, N., Adiraju, S., Wallis, S., Mat, W. Wan, Mazlan, M., Jamaluddin, M., Hasan, M., Mat-Nor, M. and Roberts, J. (2020). The DECISIVE study: defining beta-lactam concentration in intensive care unit patients – the pharmacokinetics of piperacillin and meropenem in critically ill patients with conserved renal function. 31st ICC - 4th GCCMID 2019, Dubai, United Arab Emirates, 6 - 9 November 2019. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.jiph.2020.01.129 |
|
2019 Journal Article Ceftolozane–tazobactam in an elastomeric infusion device for ambulatory care: an in vitro stability studyRaby, Edward, Naicker, Saiyuri, Sime, Fekade Bruck, Manning, Laurens, Wallis, Steven C., Pandey, Saurabh and Roberts, Jason A. (2019). Ceftolozane–tazobactam in an elastomeric infusion device for ambulatory care: an in vitro stability study. European Journal of Hospital Pharmacy, 27 (e1) e19002093, e84-e86. doi: 10.1136/ejhpharm-2019-002093 |
|
2019 Journal Article Saturable elimination of piperacillin in critically ill patients: implications for continuous infusionDhaese, S.A.M., Colin, P., Willems, H., Heffernan, A., Gadeyne, B., Van Vooren, S., Depuydt, P., Hoste, E., Stove, V., Verstraete, A.G., Lipman, J., Roberts, J.A. and De Waele, J.J. (2019). Saturable elimination of piperacillin in critically ill patients: implications for continuous infusion. International Journal of Antimicrobial Agents, 54 (6), 741-749. doi: 10.1016/j.ijantimicag.2019.08.024 |
|
2019 Journal Article Pharmacokinetics of enteric coated mycophenolate sodium in lupus nephritis (POEMSLUN)Ranganathan, Dwarakanathan, Abdul-Aziz, Mohd H., John, George T., McWhinney, Brett C., Fassett, Robert G., Healy, Helen, Kubler, Paul, Lim, Aaron, Lipman, Jeffrey, Purvey, Megan, Roberts, Matthew, Reyaldeen, Reza, Ungerer, Jacobus and Roberts, Jason A. (2019). Pharmacokinetics of enteric coated mycophenolate sodium in lupus nephritis (POEMSLUN). Therapeutic Drug Monitoring, 41 (6), 703-713. doi: 10.1097/ftd.0000000000000658 |
|
2019 Journal Article Update in antibiotic therapy in intensive care unit: report from the 2019 Nîmes International SymposiumLeone, Marc, Roberts, Jason A., Bassetti, Matteo, Bouglé, Adrien, Lavigne, Jean-Philippe, Legrand, Matthieu, Neely, Michael, Paiva, José-Artur, Payen, Didier, Rello, Jordi, Roger, Claire, Sjövall, Fredrik and Jung, Boris (2019). Update in antibiotic therapy in intensive care unit: report from the 2019 Nîmes International Symposium. Anaesthesia Critical Care and Pain Medicine, 38 (6), 647-656. doi: 10.1016/j.accpm.2019.09.009 |
|
2019 Journal Article Pharmacokinetics and pharmacodynamics of anti-infective agents during continuous veno-venous hemofiltration in critically ill patients: lessons learned from an ancillary study of the IVOIRE trialBreilh, Dominique, Honore, Patrick M., De Bels, David, Roberts, Jason A., Gordien, Jean Baptiste, Fleureau, Catherine, Dewitte, Antoine, Coquin, Julien, Roze, Hadrien, Perez, Paul, Attou, Rachid, Redant, Sebastien, Kugener, Luc, Saux, Marie-Claude, Spapen, Herbert D., Ouattare, Alexandre and Joannes-Boyau, Olivier (2019). Pharmacokinetics and pharmacodynamics of anti-infective agents during continuous veno-venous hemofiltration in critically ill patients: lessons learned from an ancillary study of the IVOIRE trial. Journal of Translational Internal Medicine, 7 (4), 155-169. doi: 10.2478/jtim-2019-0031 |
|
2019 Journal Article Linezolid dosing in patients with liver cirrhosis: standard dosing risk toxicityLuque, Sonia, Muñoz-Bermudez, Rosana, Echeverría-Esnal, Daniel, Sorli, Luisa, Campillo, Nuria, Martínez-Casanova, Javier, González-Colominas, Elena, Álvarez-Lerma, Francisco, Horcajada, Juan Pablo, Grau, Santiago and Roberts, Jason A. (2019). Linezolid dosing in patients with liver cirrhosis: standard dosing risk toxicity. Therapeutic Drug Monitoring, 41 (6), 732-739. doi: 10.1097/FTD.0000000000000665 |
|
2019 Journal Article Antimicrobial de-escalation in critically ill patients: a position statement from a task force of the European Society of Intensive Care Medicine (ESICM) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Critically Ill Patients Study Group (ESGCIP)Tabah, Alexis, Bassetti, Matteo, Kollef, Marin H., Zahar, Jean-Ralph, Paiva, José-Artur, Timsit, Jean-Francois, Roberts, Jason A., Schouten, Jeroen, Giamarellou, Helen, Rello, Jordi, De Waele, Jan, Shorr, Andrew F., Leone, Marc, Poulakou, Garyphallia, Depuydt, Pieter and Garnacho-Montero, Jose (2019). Antimicrobial de-escalation in critically ill patients: a position statement from a task force of the European Society of Intensive Care Medicine (ESICM) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Critically Ill Patients Study Group (ESGCIP). Intensive Care Medicine, 46 (2), 245-265. doi: 10.1007/s00134-019-05866-w |
